INSM Live signaler | Maksimer profitt med Getagraph.com

KJøP 92832 min ago

@ $28.97

Utstedt: 28 feb 2024 @ 15:30

Avkastning: -11.43%

Forrige signal: feb 27 - 21:07

Forrige signal: Selg

Avkastning: -1.16 %

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 22:00):

Stats
Dagens volum	1.44M
Gjennomsnittsvolum	1.77M
Markedsverdi	3.81B
EPS	$0 ( 2024-02-22 )
Neste inntjeningsdato	( $-1.210 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.81
ATR14	$0.0320 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	Lewis William	Buy	50 000	Common Stock
2024-02-28	Lewis William	Buy	50 000	Stock Option (right to buy)
2024-02-28	Sharoky Melvin Md	Sell	3 600	Common Stock
2024-02-28	Sharoky Melvin Md	Buy	1 200	Common Stock
2024-02-28	Sharoky Melvin Md	Buy	1 200	Common Stock

INSIDER POWER
36.62
Last 100 transactions
Buy: 1 120 971 \| Sell: 555 042

Volum Korrelasjon

Lang: -0.24 (neutral)

Kort: -0.65 (weak negative)

Signal:(67.463) Neutral

Insmed Inc Korrelasjon

10 Mest positive korrelasjoner
ONBPP	0.872
CNDT	0.868
ANNX	0.868
PRAX	0.866
NETE	0.854
ICCC	0.853
WAFDP	0.851
DCOMP	0.847
SRAX	0.846
TTEC	0.846

10 Mest negative korrelasjoner
RMRM	-0.836
PAIC	-0.832
SVAC	-0.829
EPZM	-0.82
SPRT	-0.816
UNCY	-0.816
TYHT	-0.811
CNST	-0.806
CNCE	-0.804
DRNA	-0.801

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Insmed Inc Korrelasjon - Valuta/Råvare

0.10
( neutral )

0.52
( weak )

0.00
( neutral )

-0.16
( neutral )

-0.09
( neutral )

-0.14
( neutral )

Insmed Inc Økonomi

Annual	2023
Omsetning:	$305.21M
Bruttogevinst:	$239.64M (78.52 %)
EPS:	$-5.34

FY	2023
Omsetning:	$305.21M
Bruttogevinst:	$239.64M (78.52 %)
EPS:	$-5.34

FY	2022
Omsetning:	$245.36M
Bruttogevinst:	$190.23M (77.53 %)
EPS:	$-3.91

FY	2021
Omsetning:	$188.46M
Bruttogevinst:	$144.31M (76.57 %)
EPS:	$-3.88

Financial Reports:

No articles found.

Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.